The Alzheimer's Association International Conference (AAIC) 2026 featured significant advances in neuropsychology and cognitive assessment, highlighting new cognitive tests, digital cognitive assessments, and validation studies. This page captures the key developments presented at the conference.
Key Research Themes
Digital Cognitive Assessments
AAIC 2026 showcased significant progress in digital cognitive assessment tools:
...
neuropsychology-cognitive-assessment
Overview
Mermaid diagram (expand to render)
The Alzheimer's Association International Conference (AAIC) 2026 featured significant advances in neuropsychology and cognitive assessment, highlighting new cognitive tests, digital cognitive assessments, and validation studies. This page captures the key developments presented at the conference.
Key Research Themes
Digital Cognitive Assessments
AAIC 2026 showcased significant progress in digital cognitive assessment tools:
Smartphone-based cognitive testing — attention, memory, and processing speed assessments administered via mobile applications
High correlation between smartphone cognitive tests and standard neuropsychological assessments
Sensitivity to early cognitive changes in preclinical AD
Research presented by Kaye et al. and Doraiswamy et al. demonstrated the validity of digital cognitive assessments for early detection of mild cognitive impairment ([Kaye et al., 2014](https://doi.org/10.1016/j.jalz.2013.12.017); [Doraiswamy et al., 2022](https://doi.org/10.1002/alz.12634)).
Objective Subtle Cognitive Difficulties (Obj-SCD)
New frameworks for detecting subtle cognitive changes were presented:
Valid assessment approaches for identifying Objective Subtle Cognitive Difficulties
Technology-enabled cognitive assessment including smartphone-based testing
Integration with biomarker panels for enhanced prediction of cognitive decline
Cognitive Assessment Integration with Biomarkers
Research highlighted the integration of cognitive assessments with biomarker data:
Blood + brief cognitive assessments combined for improved prediction
Correlation between fluid biomarkers (p-Tau217) and cognitive performance
Smartwatch data improving prediction of cognitive decline
Smartphone-based cognitive assessments correlating with fluid biomarkers
Clinical Trial Applications
Digital Endpoints in Clinical Trials
Cognitive assessments in clinical trials are evolving:
Remote monitoring and cognitive assessments as digital endpoints
More frequent assessment between clinic visits
Remote pre-screening to improve trial enrollment efficiency
Interim monitoring tools supplementing traditional measures
New Cognitive Tests Presented
Several novel cognitive testing approaches were highlighted:
5 Digit Cognitive Test: A smartphone-based assessment for early detection of MCI
Computerized cognitive batteries with adaptive testing
Ecological momentary assessment (EMA) for capturing naturalistic cognitive fluctuations
Neuropsychological Frameworks
MCI Criteria Updates
New neuropsychological criteria for mild cognitive impairment were discussed:
Empirically-derived cutoff scores for various cognitive domains
Sensitivity and specificity considerations
Integration with ATN (Amyloid, Tau, Neurodegeneration) biomarker framework
Domain-Specific Assessment
Research emphasized domain-specific cognitive testing:
[AAIC 2026: Synaptic Dysfunction and Neural Circuits](/events/aaic-2026/synaptic-dysfunction-neural-circuits)
References
[Kaye J, et al. Unobtrusive measurement of daily computer use to detect mild cognitive impairment. Alzheimers Dement. 2014](https://doi.org/10.1016/j.jalz.2013.12.017)
[Doraiswamy PM, et al. 5 Digit Cognitive Test: A novel smartphone-based assessment for early detection of mild cognitive impairment. Alzheimers Dement. 2022](https://doi.org/10.1002/alz.12634)
[Bondi MW, et al. Neuropsychological criteria for mild cognitive impairment. 2022](https://pubmed.ncbi.nlm.nih.gov/35653719/)